Evaluation of a pre‐exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens

Men who have sex with men (MSM) and transgender women (TGW) are two key populations (KPs) in Thailand at high risk for HIV. Uptake and scale‐up of pre‐exposure prophylaxis (PrEP) among them has been slow. We used data from Princess PrEP, Thailand’s largest KP‐led PrEP programme, to operationalize PrEP service cascades. We identified gaps and pointed out where additional data are needed to inform a larger HIV prevention cascade.

[1]  P. Phanuphak,et al.  Linkages to HIV confirmatory testing and antiretroviral therapy after online, supervised, HIV self‐testing among Thai men who have sex with men and transgender women , 2020, Journal of the International AIDS Society.

[2]  T. Chun,et al.  Decreased tenofovir diphosphate concentrations in a transgender female cohort: Implications for HIV pre-exposure prophylaxis (PrEP). , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  P. Phanuphak,et al.  Drug‐drug interactions between feminizing hormone therapy and pre‐exposure prophylaxis among transgender women: the iFACT study , 2019, Journal of the International AIDS Society.

[4]  L. Bekker,et al.  Global PrEP roll-out: recommendations for programmatic success. , 2019, The lancet. HIV.

[5]  T. Hallett,et al.  HIV prevention cascades: A unifying framework to replicate the successes of treatment cascades , 2019, The lancet. HIV.

[6]  D. Cooper,et al.  Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. , 2018, The lancet. HIV.

[7]  P. Phanuphak,et al.  Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. , 2018, Sexual health.

[8]  P. Phanuphak,et al.  Characteristics and HIV epidemiologic profiles of men who have sex with men and transgender women in key population-led test and treat cohorts in Thailand , 2018, PloS one.

[9]  D. Cooper,et al.  Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial , 2018, BMC Public Health.

[10]  G. Zimet,et al.  Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data , 2018, AIDS and Behavior.

[11]  A. Pozniak,et al.  Rapidly declining HIV infection in MSM in central London. , 2017, The lancet. HIV.

[12]  M. Boffito,et al.  InterPrEP. Internet-based pre-exposure prophylaxis with generic tenofovir DF/emtricitabine in London: an analysis of outcomes in 641 patients , 2017, Journal of virus eradication.

[13]  J. Gallant,et al.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission. , 2016, The New England journal of medicine.

[14]  J. Molina,et al.  [Pre-exposure prophylaxis of HIV infection ]. , 2014, La Revue du praticien.

[15]  S. Hull,et al.  Perceived Risk as a Moderator of the Effectiveness of Framed HIV Test Promotion Messages Among Women , 2010 .